Skip to main content

Table 3 Patient and disease characteristics in 5,493 individuals younger than 65 years who are working or not working in the QUEST-RA study in countries with a high (>24K USD) or low (<11K USD) GDP

From: Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study

 

Individuals younger than 65 years old

 

All countries

High-GDP countries

Low-GDP countries

 

Working

Not working

P valuea

Working

Not working

P valuea

Working

Not working

P valuea

Number

2,590

2,903

 

1,436

1,347

 

1,154

1,556

 

Patient characteristics

         

   Females, percentage

76%

85%

< 0.001

72%

81%

< 0.001

82%

89%

< 0.001

   Age in years, mean

46

52

< 0.001

47

54

< 0.001

45

50

< 0.001

   Disease duration in years, mean

8.3

11

< 0.001

8.7

12

< 0.001

7.8

11

< 0.001

   Rheumatoid factor-positive, percentage

72%

75%

0.004

70%

75%

0.001

75%

76%

0.64

   Erosive disease, percentage

53%

65%

< 0.001

51%

62%

< 0.001

56%

69%

< 0.001

Disease activity measures

         

   DAS28 (0 to 9.1), mean

4.0

4.6

< 0.001

3.3

3.9

< 0.001

4.8

5.2

< 0.001

   ESR, median

20

26

< 0.001

14

18

< 0.001

28

32

< 0.001

   SJC (0 to 28), median

2

3

< 0.001

1

2

< 0.001

3

4

0.002

   TJC (0 to 28), median

3

5

< 0.001

1

2

< 0.001

7

8

< 0.001

   Physician global (0 to 10), median

2.1

2.8

< 0.001

1.5

1.9

< 0.001

3.0

3.8

< 0.001

Patient self-report

         

   HAQ physical function (0 to 3), median

0.63

1.1

< 0.001

0.50

0.88

< 0.001

0.88

1.3

< 0.001

   Pain VAS (0 to 10), median

3.2

4.5

< 0.001

2.3

3.8

< 0.001

4.2

4.9

< 0.001

   Patient global VAS (0 to 10), median

3.3

4.6

< 0.001

2.4

3.6

< 0.001

4.3

5.0

< 0.001

   Fatigue VAS (0 to 10), median

3.9

4.8

< 0.001

3.2

4.2

< 0.001

4.5

5.2

< 0.001

   Psychological HAQ (0 to 3), mean

0.79

0.94

< 0.001

0.60

0.82

< 0.001

0.87

1.1

< 0.001

Treatment-related variables

         

   Number of DMARDs ever taken, mean

2.42

2.73

< 0.001

2.6

3.1

< 0.001

2.2

2.4

< 0.001

   Biologics ever, percentage of patients

22%

21%

0.60

32%

35%

0.12

8.5%

9.0%

0.65

  1. aUnadjusted P values are presented. DAS28, disease activity score using 28 joint counts; DMARD, disease-modifying antirheumatic drug; ESR, erythrocyte sedimentation rate; GDP, gross domestic product; HAQ, Health Assessment Questionnaire; QUEST-RA, Quantitative Standard Monitoring of Patients with Rheumatoid Arthritis; SJC, swollen joint count; TJC, tender joint count; USD, US dollars; VAS, visual analog scale.